Skip to main content

Department of Pharmacology Archives

How strep grabs on to platelets

Apr. 20, 2016—New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.

Read more


Eye of a cytokine storm

Mar. 9, 2016—A new animal model can be used to “dissect” the inflammatory response to infection.

Read more


Schizophrenia expert Coyle set for next Flexner Discovery Lecture

Mar. 3, 2016—Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10.

Read more


Grant bolsters rheumatoid arthritis research

Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.

Read more


McLaughlin named a reviewing editor for neuroscience journal

Jan. 21, 2016—BethAnn McLaughlin, Ph.D., a neuroscientist at Vanderbilt University Medical Center, has been invited to serve as a reviewing editor for the Journal of Neuroscience, the flagship publication of the Society of Neuroscience, one of the world’s largest scientific societies.

Read more


New method aids heart disease studies, drug discovery efforts

Jan. 14, 2016—A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.

Read more


VUMC’s Baganz honored by Society for Neuroscience

Nov. 12, 2015—For her contributions to public communication, outreach and education about neuroscience, Nicole Baganz, Ph.D., a postdoctoral fellow in Pharmacology, received the 2015 Next Generation Award from the Society for Neuroscience.

Read more


Study further links immune response, serotonin signaling

Nov. 5, 2015—Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.

Read more


Inflammation, obesity and diabetes

Oct. 29, 2015—Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.

Read more


St. Jude researcher presents seminar Nov. 6

Oct. 16, 2015—St. Jude Children's Research Hospital's Stacey Ogden presents a seminar Nov. 6.

Read more


The yin and yang of COX-2

Oct. 2, 2015—New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.

Read more


Collaboration seeks to develop new therapies for bone, other diseases

Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

Read more


Page 5 of 9« First...23456789

Upcoming Events

MORE EVENTS »